Clinical Trials in Minneapolis

Showing 4681-4700 of 11,007 trials

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT05077423

Pediatric patients (\<21 years at study entry) with relapsed or refractory acute myeloid leukemia (AML) will be treated with CD33\*CD3 a bispecific antibody to investigate the safety and tolerability of the drug.

AML, Childhood

Y-mAbs Therapeutics3 participantsStarted May 2022

Birmingham, Alabama, United States • Orange, California, United States • San Francisco, California, United States +10 more locations

TERMINATEDPhase 3< 1 mile

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

NCT04163900

NuTide:121 compares NUC-1031 with gemcitabine, both in combination with cisplatin, in patients with previously untreated advanced biliary tract cancer. The primary hypotheses are: * The combination of NUC-1031 plus cisplatin prolongs overall survival compared to the gemcitabine plus cisplatin standard of care * The combination of NUC-1031 plus cisplatin increases overall response rate compared to the gemcitabine plus cisplatin standard of care

Biliary Tract Cancer

NuCana plc773 participantsStarted Dec 2019

Tucson, Arizona, United States • Tucson, Arizona, United States • Whittier, California, United States +122 more locations

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Find Trials by Condition in Minneapolis

Dimethyl Fumarate (DMF) Observational Study

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Food Related Video and the Incidence of Postoperative Nausea and Vomiting

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

A Study to Assess S-217622 in Participants With Mild and Moderate Hepatic Impairment and Healthy Control Participants

Air Optix Night and Day Aqua (AONDA) Retrospective Study 1

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Study of Diroximel Fumarate in the Real-World Setting

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)